Y Intercept Hong Kong Ltd Raises Stake in Enhabit, Inc. $EHAB

Y Intercept Hong Kong Ltd increased its holdings in Enhabit, Inc. (NYSE:EHAB) by 188.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 218,284 shares of the company’s stock after purchasing an additional 142,556 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Enhabit were worth $1,748,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Osaic Holdings Inc. grew its stake in Enhabit by 337.5% during the second quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock worth $25,000 after buying an additional 2,018 shares during the period. State of Alaska Department of Revenue bought a new stake in shares of Enhabit in the 3rd quarter valued at approximately $27,000. Tower Research Capital LLC TRC grew its position in shares of Enhabit by 82.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock valued at $44,000 after buying an additional 2,059 shares during the last quarter. Russell Investments Group Ltd. boosted its position in Enhabit by 523.1% during the 2nd quarter. Russell Investments Group Ltd. now owns 5,795 shares of the company’s stock valued at $56,000 after purchasing an additional 4,865 shares during the period. Finally, Jones Financial Companies Lllp grew its position in shares of Enhabit by 110,987.5% during the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock worth $78,000 after acquiring an additional 8,879 shares during the last quarter.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Truist Financial set a $10.50 target price on Enhabit and gave the company a “hold” rating in a research note on Wednesday, January 7th. TD Cowen upgraded shares of Enhabit to a “buy” rating in a research report on Tuesday, January 13th. Deutsche Bank Aktiengesellschaft upgraded Enhabit to a “buy” rating in a report on Tuesday, January 13th. UBS Group upgraded shares of Enhabit from a “neutral” rating to a “buy” rating and boosted their price target for the company from $8.50 to $12.00 in a report on Thursday, January 8th. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Enhabit in a research note on Tuesday, December 16th. Six analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $12.10.

Enhabit Stock Performance

Shares of NYSE EHAB opened at $10.54 on Friday. Enhabit, Inc. has a 52 week low of $6.47 and a 52 week high of $11.35. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.58 and a current ratio of 1.58. The business’s 50-day simple moving average is $9.74 and its 200-day simple moving average is $8.46. The firm has a market cap of $533.43 million, a price-to-earnings ratio of -42.16 and a beta of 1.66.

Enhabit (NYSE:EHAB) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.05. Enhabit had a negative net margin of 1.14% and a positive return on equity of 3.91%. The business had revenue of $263.60 million during the quarter, compared to the consensus estimate of $267.08 million. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. As a group, equities research analysts expect that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.